Leukotriene D4

Leukotriene D4

0Leukotriene D4 (LTD4) is a bioactive lipid that belongs to the leukotriene family. It is produced by the enzyme 5-lipoxygenase in leukocytes and plays a significant role in the pathophysiology of inflammatory and allergic reactions.

Production

Leukotriene D4 is produced from leukotriene C4 (LTC4) by the action of the enzyme gamma-glutamyl transpeptidase. This enzyme removes the glutamic acid residue from LTC4, resulting in the formation of LTD4.

Function

LTD4 is a potent mediator of inflammation. It exerts its effects by binding to the cysteinyl leukotriene receptor 1 (CysLT1) and cysteinyl leukotriene receptor 2 (CysLT2) on the surface of target cells. This binding triggers a series of intracellular events that lead to bronchoconstriction, increased vascular permeability, and eosinophil recruitment, all of which contribute to the inflammatory response.

Role in Disease

LTD4 has been implicated in a number of diseases, including asthma, allergic rhinitis, and inflammatory bowel disease. In these conditions, the overproduction of LTD4 leads to excessive inflammation and tissue damage. Therefore, drugs that block the production or action of LTD4, such as leukotriene receptor antagonists and 5-lipoxygenase inhibitors, are used in the treatment of these diseases.

See Also

• Leukotriene
• 5-lipoxygenase
• Leukotriene receptor antagonist
• Inflammation

Resources

Latest articles - Leukotriene D4

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Leukotriene D4 for any updates.

‎